Finally, understanding the mechanism that lies upstream of aberrant TDP-43 loss of nuclear localization may prove to be the most encompassing approach to therapy—not only for ALS—but the other disorders of TDP-43 pathology. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.